Manhattan Lasik Center
Manhattan Lasik Center is a private multi-location ophthalmology practice in the New York Tri-State area specializing in elective laser vision correction (LASIK, ZEISS SMILE/SMILE Pro, EVO ICL) and serving consumer patients seeking surgical alternatives to glasses and contact lenses.
- Company typePrivate
- Founded2004
- HeadquartersNew York, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Manhattan Lasik Center does
Manhattan Lasik Center is a private multi-location ophthalmology practice specializing in laser vision correction, founded in 1998 (per firmographic data; 2004 per company history) by Dr. Kevin Niksarli in Midtown Manhattan. The practice operates four clinical sites across the New York Tri-State area (Manhattan, Roslyn/Long Island, West Harrison/Westchester, and Paramus/New Jersey) and serves a consumer patient base seeking elective vision correction, including those not candidates for laser procedures. Service offerings span refractive surgery for myopia, hyperopia, and astigmatism across multiple modalities: ZEISS SMILE and SMILE Pro (flapless lenticule extraction), Ultra-Thin Flap Bladeless LASIK (with 80-micron flaps), PRK/LASEK/Epi-LASIK, EVO ICL implantation, monovision correction, and keratopigmentation (cosmetic eye color change).
The practice is built on a ZEISS-centered technology stack, operating four ZEISS VisuMax femtosecond lasers (the only US center at this scale), supplemented by NIDEK excimer lasers, PENTACAM HR tomography, ORBSCAN 2 topographical mapping, and MARCO TRS refraction systems. The SMILE Pro platform adds AI-assisted alignment via the VisuMax 800. The center claims status as the first in the Northeast to offer ZEISS SMILE (2017) and the first and only in the Tri-State to offer SMILE Pro (2024-2025), with 100,000+ total procedures performed.
The business model is direct-to-consumer elective surgery with one-time procedure fees (LASIK from $2,995 per both eyes promotional; SMILE Pro and EVO ICL at premium pricing; keratopigmentation at $12,000). Patient financing through CareCredit and Alphaeon with 0% APR up to 24 months is a key revenue enabler. Insurance discounts are available through major vision plans. GTM is multi-channel: SEO-optimized website content, online self-tests via Typeform, on-demand webinars, virtual consultations, SMS-driven lead capture, and a 20+ affiliated optometrist network across NY, NJ, and PA that generates referrals and handles post-operative care. The practice is physician-led, with no disclosed external capital, PE ownership, or M&A activity.
Manhattan Lasik Center firmographics
Firmographics- Name
- Manhattan Lasik Center
- Legal name
- Manhattan LASIK Center
- Website
- https://manhattanlasikcenter.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Manhattan Lasik Center is a private multi-location ophthalmology practice in the New York Tri-State area specializing in elective laser vision correction (LASIK, ZEISS SMILE/SMILE Pro, EVO ICL) and serving consumer patients seeking surgical alternatives to glasses and contact lenses.
- Ownership category
- akta.pro rank
Manhattan Lasik Center industry classification
Industry- Product category
- Refractive Surgery / Laser Vision Correction Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)
- akta.pro secondary industry
- Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO)
Keywords
Where Manhattan Lasik Center is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Manhattan Lasik Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- LASIK and Vision Correction Procedures: One-time surgical fees for LASIK, SMILE, SMILE Pro, and other vision correction procedures. Pricing varies by procedure type and prescription complexity. All-inclusive pricing covers consultation, follow-up visits, and enhancements within one year.
- Healthcare Financing: Third-party financing through CareCredit and Alphaeon enabling patients to pay over time. Offers 6, 12, 18, or 24-month zero interest promotional periods. Patient financing is a key revenue enabler.
- EVO ICL Implantation: Implantable Collamer Lens procedure for patients not candidates for laser correction. Premium pricing for this reversible vision correction option.
- Keratopigmentation: Cosmetic eye color change procedure at $16,000 (currently promotional pricing at $12,000). Elective cosmetic procedure not covered by insurance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Bladeless LASIK starting price |
| Transaction based/ take rate | Monthly | Daily cost financing option |
| One time/ perpetual license | Pay-as-you-go | Keratopigmentation cosmetic procedure |
| Transaction based/ take rate | Pay-as-you-go | Insurance and corporate discounts |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Manhattan Lasik Center product offering
Product offeringCore offering
Manhattan LASIK Center is a multi-location ophthalmology practice that performs elective laser vision correction procedures—including ZEISS SMILE and SMILE Pro, bladeless LASIK with 80-micron flaps, EVO ICL implantation, PRK/LASEK, monovision, and keratopigmentation—on adult patients seeking to reduce dependence on glasses or contact lenses. The practice combines same-day consultation and surgery at four Tri-State clinics with affiliated optometrist post-operative care and financing through CareCredit and Alphaeon.
Product overview
Manhattan LASIK Center offers a comprehensive suite of laser vision correction procedures and diagnostic technologies across four locations (Manhattan, Long Island, New Jersey, and Westchester). The core portfolio centers on three primary procedure types: ZEISS SMILE/SMILE Pro (flapless lenticule extraction), Ultra-Thin Flap Bladeless LASIK (femtosecond laser-assisted flap creation with 80-micron flaps), and Advanced Surface Treatments (PRK/LASEK). Supporting services include EVO ICL implantation, keratopigmentation (cosmetic eye color change), and monovision correction. The practice operates with advanced diagnostic equipment including the ZEISS VisuMax FS 500 laser, NIDEK excimer lasers, Pentacam HR imaging, Orbscan topography, and MARCO TRS refraction systems. Financing is available through CareCredit and Alphaeon credit programs.
Differentiator
Problem solved
Functional benefit
Products and services
- ZEISS SMILE Pro Next-generation flapless laser vision correction procedure using AI-assisted ZEISS VisuMax 800 platform, offering 2x faster treatment times (under 10 seconds per eye) with enhanced precision and comfort for correcting nearsightedness and astigmatism. Available only at this center in the Tri-State area.
- ZEISS SMILE Third-generation flapless, minimally invasive laser vision correction that creates and extracts a lenticule through a 3.5mm incision using the ZEISS VisuMax femtosecond laser to correct nearsightedness and astigmatism. Preserves corneal biomechanical strength and reduces dry-eye risk.
- Ultra-Thin Flap Bladeless LASIK with ZEISS VisuMax FS 500 All-laser LASIK procedure using the ZEISS VisuMax femtosecond laser to create the world's thinnest 80-micron corneal flaps, resulting in stronger cornea, better visual outcomes, and reduced postoperative dryness compared to traditional 100–120 micron flaps. Promotional pricing starting at $2,995 for both eyes.
- EVO ICL (Implantable Collamer Lens) Soft, flexible implantable Collamer Lens positioned between the iris and natural lens to correct vision and reduce dependency on glasses or contact lenses. FDA-approved since 2005, reversible, and suitable for patients not candidates for laser procedures such as those with thin corneas, dry eyes, or high myopia.
- Keratopigmentation Elective cosmetic eye color change procedure using bladeless femtosecond laser to create corneal channels for placement of specially prepared color pigments. Available in colors including Riviera Blue, Emerald Green, and Honey. Currently $12,000 with $4,000 promotional discount (originally $16,000), including consultation, diagnostic testing, and 12 months of free follow-up and touch-ups.
- PRK, LASEK, Epi-LASIK (Advanced Surface Treatment) Alternative surface laser vision correction procedures for patients with thinner corneas or atypical corneal shapes. Removes the epithelium without creating a flap, then reshapes the cornea with excimer laser.
- Monovision Surgical option for presbyopic patients where the dominant eye is corrected for distance vision while the other eye is left slightly nearsighted to allow near/reading vision, reducing dependency on reading glasses.
- Contoura Vision Topography-Guided LASIK Topography-guided LASIK that uses advanced technology to provide detailed data on unique eye characteristics for customized treatment plans that correct both eye shape and corneal surface texture.
Quantifiable outcome
- 90% of patients achieve 20/20 vision or better with SMILE
- +4 more outcomes
Companies that use Manhattan Lasik Center
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
Manhattan Lasik Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature8 records
Manhattan Lasik Center partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Affiliated Optometrists NetworkcorePartnership with 20+ optometrists across New York, New Jersey, and Pennsylvania for post-operative care and annual eye exams. Network includes Dr. James Aversa (Hasbrouck Heights, NJ), Dr. Andrew Balysky (Chester, NJ), Dr. Robert Guela (New York, NY), Dr. Charles Hollander (New York, NY), and others who refer patients and provide ongoing care.
- Neoris EyesminorPartner for keratopigmentation (eye color change) procedure. Neoris Eyes has been investing in research to improve colorants for corneal pigmentation procedures.
- ZEISS (Carl Zeiss Meditec)coreTechnology partner providing VisuMax femtosecond lasers (FS 500 and VisuMax 800), the core technology platform for LASIK and SMILE procedures. Manhattan LASIK Center is the only center in the US with 4 ZEISS VisuMax femtosecond lasers and the first in the Northeast to offer ZEISS SMILE and SMILE Pro.
Scale indicators11 records
Recent moves8 records
Expansion highlights5 records
Manhattan Lasik Center competitors and assessment
Company assessmentDirect peers
- LASIKPlus: National US LASIK provider offering bladeless LASIK and PRK with a fixed-price model. Comparable in core refractive surgery offering and consumer-direct GTM, with broader geographic reach than Manhattan LASIK Center.
- The LASIK Vision Institute: National low-cost LASIK provider emphasizing affordability and financing. Comparable in elective refractive surgery offering but competes at a different price point than Manhattan LASIK Center's premium positioning.
- Dello Russo Laser Vision: Long-established Northeast refractive surgery practice (NY/NJ) offering LASIK and related vision correction. Direct regional competitor with overlapping Tri-State geography and similar surgeon-led model.
- Kraff Eye Institute: Chicago-based premium refractive surgery practice offering LASIK, PRK, and ICL with strong surgeon-led brand. Comparable as a premium, surgeon-anchored refractive surgery practice competing in a major US metro.
- TLC Laser Eye Centers: One of the largest US LASIK and refractive surgery chains with multiple locations across North America. Directly comparable to Manhattan LASIK Center in core service offering (LASIK, PRK, SMILE), target consumer market, and physician-led model.
Others
- Carl Zeiss Meditec (ZEISS): Manufacturer of the VisuMax femtosecond laser and SMILE/SMILE Pro platforms. Not a direct competitor but the core technology supplier to Manhattan LASIK Center and to refractive surgery broadly, shaping the competitive landscape.
- STAAR Surgical: Manufacturer of the EVO ICL (Implantable Collamer Lens) used at Manhattan LASIK Center. Enabling supplier rather than competitor; comparable as a strategic partner shaping the refractive surgery technology stack.
Regional players
- LASIK MD: Canada's largest provider of laser vision correction with extensive clinic network. Highly comparable in core refractive surgery offering and premium consumer GTM, but primarily serves Canadian rather than US patients.
Broad incumbents
- Cleveland Clinic Cole Eye Institute: Major academic health system offering refractive surgery (LASIK, PRK, ICL) within a broader ophthalmology service line. Comparable in refractive surgery capability but operates inside an academic multispecialty hospital system rather than as a focused refractive center.
- OCLI Vision: Multi-specialty ophthalmology group with refractive surgery (LASIK, PRK, ICL) plus broader eye-care services across the Northeast. Comparable in refractive surgery capabilities and Tri-State presence, but operates a wider portfolio of ophthalmic services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Manhattan Lasik Center social profiles
Digital presenceManhattan Lasik Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Manhattan Lasik Center leadership team
Management profileNumber of profiles
Profiles2 records
Manhattan Lasik Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Manhattan Lasik Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Manhattan Lasik Center
What does Manhattan Lasik Center do?
Manhattan LASIK Center is a multi-location ophthalmology practice that performs elective laser vision correction procedures—including ZEISS SMILE and SMILE Pro, bladeless LASIK with 80-micron flaps, EVO ICL implantation, PRK/LASEK, monovision, and keratopigmentation—on adult patients seeking to reduce dependence on glasses or contact lenses. The practice combines same-day consultation and surgery at four Tri-State clinics with affiliated optometrist post-operative care and financing through CareCredit and Alphaeon.
Is Manhattan Lasik Center a public or private company?
Manhattan Lasik Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Manhattan Lasik Center founded?
Manhattan Lasik Center was founded in 2004. It employs 101 to 250 people.
Where is Manhattan Lasik Center based?
Manhattan Lasik Center is headquartered in New York, United States, in the North America region.
How does Manhattan Lasik Center make money?
Four revenue lines are on record. LASIK and Vision Correction Procedures are the primary driver. The others are healthcare Financing, EVO ICL Implantation and keratopigmentation.
Who are Manhattan Lasik Center's main competitors?
Direct peers on record are LASIKPlus, The LASIK Vision Institute, Dello Russo Laser Vision, Kraff Eye Institute and TLC Laser Eye Centers. Others are Carl Zeiss Meditec (ZEISS) and STAAR Surgical. LASIK MD is listed as a regional player. Broad incumbents are Cleveland Clinic Cole Eye Institute and OCLI Vision.
Does Manhattan Lasik Center have an API?
No public API is recorded for Manhattan Lasik Center.
What industry is Manhattan Lasik Center in?
Manhattan Lasik Center's product category is Refractive Surgery / Laser Vision Correction Services. Its primary akta.pro industry code is HLAKAKAF, Cornea, External Disease & Refractive Surgery (LASIK/PRK), with a secondary code of HLAKAKAO, Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery). Its NAICS code is 62111 and its SIC code is 8011.